Header cover image

Finnish (OMX) Healthcare Sector Analysis

UpdatedMay 29, 2024
DataAggregated Company Financials
Companies15
  • 7D-0.1%
  • 3M4.1%
  • 1Y-5.7%
  • YTD-1.4%

The Healthcare is pretty flat in the last 7 days, but Nanoform Finland Oyj has stood out, gaining 14%. As for the longer term, the industry has declined 5.7% in the last year. Looking forward, earnings are forecast to grow by 20% annually.

Sector Valuation and Performance

Has the Finnish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 29 May 2024€8.2b€4.9b€118.1m27.3x69.1x1.7x
Fri, 26 Apr 2024€7.6b€4.9b€104.6m31.1x72.6x1.6x
Sun, 24 Mar 2024€7.4b€4.8b€108.1m29.3x68.6x1.5x
Tue, 20 Feb 2024€8.2b€4.8b€110.2m27.3x74.1x1.7x
Thu, 18 Jan 2024€8.8b€4.8b€135.4m33.3x65.1x1.8x
Sat, 16 Dec 2023€7.6b€4.8b€135.4m29.6x56.3x1.6x
Mon, 13 Nov 2023€7.5b€4.8b€134.3m29.7x55.5x1.6x
Wed, 11 Oct 2023€7.8b€5.0b€270.4m27.2x29x1.6x
Fri, 08 Sep 2023€7.8b€5.0b€269.6m26.4x29x1.6x
Sun, 06 Aug 2023€7.3b€5.0b€277.7m24.6x26.3x1.5x
Tue, 04 Jul 2023€8.2b€5.0b€315.2m39.3x26x1.6x
Thu, 01 Jun 2023€8.4b€5.0b€315.2m38.3x26.8x1.7x
Sat, 29 Apr 2023€9.0b€4.9b€328.2m41.1x27.3x1.8x
Mon, 27 Mar 2023€8.7b€5.0b€335.4m34.9x25.8x1.7x
Wed, 22 Feb 2023€9.6b€5.0b€335.6m39.1x28.7x1.9x
Fri, 20 Jan 2023€10.0b€5.3b€373.8m19.8x26.7x1.9x
Sun, 18 Dec 2022€10.2b€5.3b€373.8m18.3x27.3x1.9x
Tue, 15 Nov 2022€9.7b€5.3b€384.8m18.7x25.1x1.8x
Thu, 13 Oct 2022€9.2b€5.0b€282.1m17.2x32.7x1.8x
Sat, 10 Sep 2022€10.0b€5.0b€284.2m19.1x35x2x
Mon, 08 Aug 2022€10.5b€5.0b€288.2m20.2x36.5x2.1x
Wed, 06 Jul 2022€10.0b€4.9b€277.1m25.8x36.2x2.1x
Fri, 03 Jun 2022€9.4b€4.9b€277.1m27.3x34x1.9x
Sun, 01 May 2022€9.5b€4.9b€277.1m27.5x34.2x1.9x
Tue, 29 Mar 2022€9.9b€4.8b€279.2m29.3x35.4x2.1x
Thu, 24 Feb 2022€10.3b€4.8b€281.5m31.3x36.7x2.2x
Sat, 22 Jan 2022€9.7b€4.6b€269.9m26.6x36x2.1x
Mon, 20 Dec 2021€10.0b€4.6b€269.9m26.9x37.1x2.2x
Wed, 17 Nov 2021€10.7b€4.6b€270.3m28.7x39.4x2.3x
Fri, 15 Oct 2021€10.0b€4.6b€271.3m26x36.9x2.2x
Sun, 12 Sep 2021€9.7b€4.6b€271.3m25.2x35.7x2.1x
Tue, 10 Aug 2021€9.8b€4.6b€277.8m25.6x35.4x2.1x
Price to Earnings Ratio

36.4x


Total Market Cap: €9.8bTotal Earnings: €268.8mTotal Revenue: €4.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Finnish Healthcare Sector Price to Earnings3Y Average 38.3x202220232024
Current Industry PE
  • Investors are optimistic on the Finnish Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 69.1x which is higher than its 3-year average PE of 38.3x.
  • The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.7x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 24% per year over the last three years.
  • Meanwhile revenues for these companies have grown 3.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Finnish Healthcare sector?

FI Market-0.58%
Healthcare-0.12%
Life Sciences13.83%
Medical Equipment1.44%
Healthcare Services-0.46%
Pharma-0.67%
Biotech-2.37%
Healthtech-3.25%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio of 221x.
    • Analysts are expecting annual earnings growth of 26.3%, which is lower than the prior year's growth of 97.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 47% over the next 5 years.
  • This is better than its past earnings decline of 24% per year.
  • In contrast, the Biotech industry is expected to see its earnings decline by 18% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NANOFH Nanoform Finland Oyj€2.1913.8%
+€22.7m
-3.1%PS72.9x
MODU Modulight Oyj€1.4038.2%
+€16.4m
-38.9%PS8.6x
AIFORIA Aiforia Technologies Oyj€3.87-3.3%
€7.6m
4.6%PS46.6x
HRTIS Herantis Pharma Oyj€1.7018.9%
+€5.4m
-12.6%PE122.5x
OKDBV Oriola Oyj€0.941.5%
+€2.5m
-31.4%PS0.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PIHLIS

€9.00

Pihlajalinna Oyj

7D

-0.7%

1Y

-5.3%

AIFORIA

€3.87

Aiforia Technologies Oyj

7D

-3.3%

1Y

4.6%

BONEH

€0.37

BBS-Bioactive Bone Substitutes Oyj

7D

-2.4%

1Y

-58.9%

NXTMH

€2.80

Nexstim

7D

-2.8%

1Y

-21.8%

OKDBV

€0.94

Oriola Oyj

7D

1.5%

1Y

-31.4%

NANOFH

€2.19

Nanoform Finland Oyj

7D

13.8%

1Y

-3.1%

MODU

€1.40

Modulight Oyj

7D

38.2%

1Y

-38.9%

BRETEC

€2.66

Bioretec Oy

7D

-1.1%

1Y

8.6%

BIOBV

€2.01

Biohit Oyj

7D

1.5%

1Y

16.2%

HRTIS

€1.70

Herantis Pharma Oyj

7D

18.9%

1Y

-12.6%